CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
48 weeks of adefovir mono therapy following 48 weeks of combination therapy with peginterferon alfa-2b and adefovir leads to additional biochemical and virological improvement
DOI 10.1055/s-2006-950771
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Lütgehetmann, K Wursthorn, B Zöllner, P Buggisch, M Zankel, C Fischer, C Brosgart, J Petersen
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and aim: Administration of 48 weeks of PEG-IFN alfa-2b and adefovir (ADV) combination therapy in chronically HBV infected patients resulted in a strong suppression of cccDNA, high rates of HBsAg seroconversion, and HBeAg seroconversion and loss, respectively (Wursthorn, EASL 2005). However, most HBV patients may need long-term antiviral therapy. The aim of the study is to determine virological and serolog…
Zitieren
Zitierempfehlung
M Lütgehetmann, K Wursthorn, B Zöllner, P Buggisch, M Zankel, C Fischer, C Brosgart, J Petersen (2006) 48 weeks of adefovir mono therapy following 48 weeks of combination therapy with peginterferon alfa-2b and adefovir leads to additional biochemical and virological improvement. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-2006-950771
Mit CareLit weiterarbeiten